As we cross the midpoint of 2026, the global personal care industry is shifting from a period of regulatory preparation into one of active enforcement and stringent market oversight. For chemists and formulators, the initial months of the year were defined by the rollout of the Modernization of Cosmetics Regulation Act (MoCRA) and the first wave of ingredient bans. However, the second half of 2026 presents a more technical challenge: the synchronization of international labeling standards and the first hard deadlines for state-level chemical reporting. Navigating this landscape requires a meticulous approach to supply chain transparency and a “compliance-first” mindset in the laboratory.
- Fragrance Allergen Disclosure: The Global “Hard” Deadlines
The most labor-intensive change for the second half of the year is the mandatory listing of specific fragrance allergens.
- EU mandatory INCI Update (July 30, 2026): The updated EU INCI Glossary becomes mandatory. Formulators must ensure all product labels reflect the latest nomenclature.
- EU Expansion to 81+ Allergens (July 31, 2026): This is the final date for “placing on the market” new products that do not disclose the full expanded list of 81 fragrance allergens.
- Canada Phase 2 (August 1, 2026): Health Canada officially expands its requirements to the full 81 allergens for all new products entering the market. For chemists, this means proprietary fragrance blends must be fully audited and “unlocked” for labeling.
- U.S. State-Level PFAS Enforcement (July 1, 2026)
While some states started their bans in January, Connecticut has a unique mid-year trigger that formulators must watch.
- Connecticut Mandatory Labeling: As of July 1, 2026, any cosmetic product sold in Connecticut containing intentionally added PFAS must carry a clearly visible label indicating its presence and provide written notification to the state’s Department of Energy and Environmental Protection (DEEP).
- Formulator Task: If your formula uses PFAS for slip or water resistance and you aren’t ready to reformulate, you must ensure the “Responsible Person” has filed the required amount and purpose of the PFAS with the state by this date.
- MoCRA: The “First Anniversary” Renewals
MoCRA facility registrations are biennial, and for many, the clock is ticking this fall.
- Rolling Renewals: Because renewals are based on the anniversary of your initial registration, many facilities that registered in late 2024 (during the initial rush) will hit their two-year renewal deadline in Q3 and Q4 of 2026.
- GMP Milestone: The FDA is expected to continue its progress toward finalizing Good Manufacturing Practice (GMP) rules by the end of 2026. Formulators should audit their lab-to-production handoff processes now to ensure they align with the high standards expected in the final rule.
- EU Ingredient Restrictions: The “Sell-Through” Cliff
While the ban for some ingredients occurred earlier in the year, the “making available” (sell-through) deadlines often hit in the second half.
ULTRUS™ Product Stewardship enables material selection, compliance, sustainability and chemical management throughout the product life cycle to meet regulatory requirements and consumer demands, learn more here!
- Silver Compounds & Nano-Silver: Stricter restrictions on silver and nano-materials will see intensified inspections in the latter half of the year as transition periods end.
- Cyclic Siloxanes (cVMS): Although the 0.1% limit for D5 and D6 in rinse-off products took effect in June, Q3 and Q4 will be the first period of active market surveillance and potential “stop-sale” orders for non-compliant inventory.
Formulator’s Checklist for Q3/Q4 2026
| Priority | Action Item |
| Allergens | Transition all new product artwork to the 81-allergen disclosure list. |
| PFAS | Verify if any products sold in Connecticut need the mandatory PFAS label after July 1. |
| Registration | Check your MoCRA anniversary date to see if your biennial facility renewal is due this fall. |
| Safety | Ensure Safety Substantiation files are updated for any ingredients that were part of the 2026 Omnibus VIII updates. |
As we move toward 2027, the role of the cosmetic chemist is evolving into a hybrid of science and legal strategy. The regulatory shifts occurring in the latter half of 2026 are not merely bureaucratic hurdles but are indicative of a permanent move toward total transparency and safety accountability. By staying ahead of these Q3 and Q4 deadlines—particularly the complex fragrance allergen disclosures—formulators can protect their brands from costly market withdrawals and ensure that innovation continues to thrive within the bounds of global safety standards.
Sources:
- Why 2026 Is a Critical Year for Cosmetic Compliance – Annel
- State PFAS Bans in Cosmetics Expand Ahead of 2026 – Morgan Lewis
- Health Canada Mandates Fragrance Allergen Disclosure (August 2026) – Cosmeservice
- MoCRA Biennial Renewal 2026 Checklist – EcoMundo
- EU Restrictions on Cyclic Volatile Methyl Siloxanes (cVMS) – Critical Catalyst
The views, opinions and technical analyses presented here are those of the author or advertiser, and are not necessarily those of ULProspector.com or UL Solutions. The appearance of this content in the UL Prospector Knowledge Center does not constitute an endorsement by UL Solutions or its affiliates.
All content is subject to copyright and may not be reproduced without prior authorization from UL Solutions or the content author.
The content has been made available for informational and educational purposes only. While the editors of this site may verify the accuracy of its content from time to time, we assume no responsibility for errors made by the author, editorial staff or any other contributor.
UL Solutions does not make any representations or warranties with respect to the accuracy, applicability, fitness or completeness of the content. UL Solutions does not warrant the performance, effectiveness or applicability of sites listed or linked to in any content.